OK, here is the DD on STGI.
First, many of you were befuddled by the fact that the buys
far outnumbered the sells with regard to share volume today
and yet the price went down. This is an MM game. It's the
shareholders/buyers against the MMs. I was told by Chuck
Jordan in IR that they are very aware of the the MM problem
and they know for a fact that the MMs have it shorted at
2.00. A PR blitz will be underway regarding the company's
accomplishments to bring in new investors to remove the MMs
at the short. In fact, Chuck said that a couple of interested
parties were buying the stock today simply to remove the
float and get the crooked D&#k!>$d MMs out of the stock.
Whatever that means....
Now, To explain what STGI is all about:
ANTICORT is the drug.
Cortisol/Anticortisol concept:
Medical conditions such as AIDS, cancer, diabetes, MS, ALS,
Alzheimer's even aging all have something in common: Large
amounts of the immuno-destructive hormone, cortisol.
High levels of this hormone were previously thought to be a
result of the disease or condition itself. In Dr.
Sapse's research, he has found the opposite to be true; high
levels of cortisol is the cause of or majority cause
of these diseases.
The gist of the ANTICORT drug is to reduce and reduce
dramatically the levels of cortisol in the effected body.
Meaning that people that have these diseases may live longer
and more normal lives. In the last three years, other
companies have begun development of anti-cortisol drugs
as a result of the wider acceptance of the cortisol/anti-
cortisol treatment. ANTICORT has been approved by the FDA
to enter phase Ib/IIa in the treatment of immune deficiency
in an HIV positive population. ANTICORT is currently being
tested in a number of areas in the world on a variety of
diseases. I was told that one of the AIDS tests have been
VERY successful with regard to the use of ANTICORT.
A big deal is underway between Quintiles Transnational Corp
(NASDAQ-QTRN) and STGI to market the drug. QTRN is a market
leader in providing full service contract research, sales and
marketing services worldwide. Needless to say, this will
be a significant development for STGI. I was told in so many
words that the QTRN thing was a done deal.
Finally, Dr Sapse will have a number of engagements whereby
he will be able to detail his research and development for
the world to see.
Among these opportunities will "Investing in America" on
27 March at 2:00PM EST on CNBC. This program will also
be broadcast to a number of European countries. Dr. Sapse
has an number of other engagements as well.
Here are links to the news releases which were used to compile
the above. I also used info from the company itself as well
as two phone calls today to IR.
biz.yahoo.com
biz.yahoo.com
biz.yahoo.com
biz.yahoo.com
More news will be forthcoming in the next two weeks as
well as a reminder to watch the CNBC show on the 27th.
THIS IS NOT A REC TO BUY THE STOCK. DO YOUR OWN DD.
CALL THE COMPANY, CALL IR, READ THE NEWS, GO TO VEGAS
AND SEE THEM.
Tom |
